Navigation Links
Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Date:3/2/2013

ng, and possible success and therapeutic applications of Regeneron's products, product candidates, and research and clinical programs now underway or planned, including without limitation Dupilimab; unforeseen safety issues resulting from the administration of products and product candidates in patients; the likelihood and timing of possible regulatory approval and commercial launch of Regeneron's late-stage product candidates; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's products and product candidates; competing drugs and product candidates that may be superior to Regeneron's products and product candidates; uncertainty of market acceptance of Regeneron's products and product candidates; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates; coverage and reimbursement determinations by third-party payers, including Medicare and Medicaid; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its sales or other financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi and Bayer HealthCare, to be canceled or terminated without any further product success; and risks associated with third party intellectual property and pending or future litigation relating thereto.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2012.  Regeneron does not undertake any obligation to update publicly any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of
'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
2. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
3. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
4. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
5. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
8. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
9. Sanofi Pasteur to add 2D barcode to six more vaccines
10. Sanofi US Launches Collaborate Activate Innovation Challenge
11. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 According to a ... Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, ... Bone Metastasis) - Global Forecasts to 2019", published by ... around $462.0 Million growing at a CAGR of 11.50% ... and 57 figures spread through 195 pages and in-depth ...
(Date:3/26/2015)... A new survey of health care ... (CER) will yield improvements in health care decision-making, ... of CER in the current environment. The National ... shows that they view CER as important, expect ... and decision-making in the next three to five ...
(Date:3/26/2015)... , March 26, 2015 Zimmer Holdings, Inc. (NYSE ... mobile app designed to serve as a feature-rich resource for ... For those experiencing knee pain, the ... the causes of knee pain and helps them understand more ... safe and simple non-surgical treatment option. For those who have ...
Breaking Medicine Technology:Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Zimmer Launches New Patient Education And Engagement Mobile App For Gel-One Hyaluronate 2
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... Newport, RI (PRWEB) March 27, 2015 April ... civil war – the Sesquicentennial. To honor America’s bloodiest war ... the Fort Adams Trust presents A Tribute to the Civil ... 7:00 PM, Friday, April 17, 2015, at the Jane Pickens ... Williams, noted Civil War-Lincoln scholar, will serve as the master ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 In light ... (case number 1:15-cv-10429, U.S. District Court, District of Massachusetts; ... the Eastern District of Pennsylvania), the San Diego personal ... Helbock, A.P.C. are announcing that they are available to ... of women who were prescribed Zofran while pregnant and ...
(Date:3/26/2015)... Alamitos, Calif. (PRWEB) March 26, 2015 ... the grocery store. Fresh produce are today’s traffic magnets. ... a particular supermarket because of their produce department, according ... important than ever as people are looking to add ... National Love Your Produce Manager® Day is April 2. ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 UC Davis ... research into the origins of schizophrenia: A Silvio O. ... of only 15 such centers in the United States. ... million grant from the National Institutes of Mental Health, ... the novel hypothesis that an origin of schizophrenia may ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4
... An outbreak of Norovirus has been reported in Royal Bournemouth ... of wards 4,5,27 // and 28 to visitors. Hospital authorities ... ward areas. It does not pose any threat to other ... the next of kin are permitted to visit patients in ...
... of the International Vaccine Institute (IVI), and Hawaii Biotech ... and make a Dengue vaccine widely available for the ... tropical disease after malaria. ,Dengue fever is a ... exposed and which leads to infection in up to ...
... have suspected a connection between chronic lung diseases ... widely varying estimates about the strength of this ... different diagnosis criteria for these diseases. Addressing this ... American College of Rheumatology Annual Meeting on Nov. ...
... researchers, led by scientists at Dartmouth Medical School and ... is capable of changing muscle metabolism and performance. // ... in the management of muscle diseases. , ... AMP-activated protein kinase (or AMPK) is responsible for realizing ...
... a vaccine that activates the immune systems in colorectal ... ,During a clinical trial of 67 patients, researchers at ... were injected pre and post surgery of the cancerous ... 70 percent of patients. The November 15 issue of ...
... is a serious condition that requires extensive medical ... prone to developing another grave condition known as ... // First recognized as a disease in 1997, ... the skin, resulting in pain, muscle weakness and ...
Cached Medicine News:Health News:Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever 2Health News:Study Examines Link Between Rheumatoid Arthritis and Chronic Lung Diseases 2Health News:Dartmouth researchers zero-in on a gene that heightens muscle performance 2Health News:A novel vaccine proves a shot in the arm for colorectal cancer patients 2Health News:Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: